Varenicline: progress in smoking cessation treatment (Q36904915)

17 August 2017

1 reference

title

Varenicline: progress in smoking cessation treatment (English)

1 reference

17 August 2017

1 reference

Elbert D Glover

1

1 reference

17 August 2017

Jessica M Rath

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

1757-1767

1 reference

Development of a rational scale to assess the harm of drugs of potential misuse

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Actual causes of death in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Tobacco smoke carcinogens and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Nicotine as a typical drug of abuse in experimental animals and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Blockade of nicotine self-administration with nicotinic antagonists in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Nicotine dependence. Interface between tobacco and tobacco-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Pharmacology of nicotine: addiction and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

The effects of nicotine on brain neurotransmitter systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Characterization of spontaneous and precipitated nicotine withdrawal in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Effects of abstinence from tobacco: valid symptoms and time course

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Clinical practice. Treatment of tobacco use and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Relapse and maintenance issues for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Use of knock-out mice to determine the molecular basis for the actions of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Neuronal nicotinic receptor subtypes: defining therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Nicotinic acetylcholine receptors and the regulation of neuronal signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

A double-blind study evaluating the long-term safety of varenicline for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.11.1757

10.1517/14656566.8.11.1757

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference